Ibrutinib is an effective treatment of autoimmune haemolytic anaemia in chronic lymphocytic leukaemia
- 25 February 2015
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 170 (5), 734-736
- https://doi.org/10.1111/bjh.13328
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- New Strategies in Chronic Lymphocytic Leukemia: Shifting Treatment ParadigmsClinical Cancer Research, 2014
- A new hope: novel therapeutic approaches to treatment of chronic lymphocytic leukaemia with defects in TP53British Journal of Haematology, 2014
- Autoimmune cytopenias in chronic lymphocytic leukemiaAmerican Journal of Hematology, 2014
- The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancyProceedings of the National Academy of Sciences of the United States of America, 2010
- Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisoneLeukemia & Lymphoma, 2010
- Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosisLeukemia & Lymphoma, 2009
- Autoimmune Complications of Chronic Lymphocytic LeukemiaSeminars in Oncology, 2006
- Chronic lymphocytic leukemic (CLL) cells secrete multispecific autoantibodiesJournal of Autoimmunity, 1988
- Autoimmunity in chronic lymphocytic leukaemia.Journal of Clinical Pathology, 1986